Pages that link to "Q36767450"

The following pages link to Serum pepsinogen and gastric cancer screening (Q36767450):

Displaying 31 items.

• Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis (Q26778122) (← links)
• Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis (Q33813676) (← links)
• Postprandial fullness correlates with rapid inflow of gastric content into duodenum but not with chronic gastritis. (Q34107934) (← links)
• The role of serum pepsinogen in the detection of gastric cancer (Q34206645) (← links)
• Anti-Helicobacter pylori activities of FEMY-R7 composed of fucoidan and evening primrose extract in mice and humans (Q34302727) (← links)
• Assessment of gastroesophageal reflux disease by serodiagnosis of Helicobacter pylori-related chronic gastritis stage (Q34993833) (← links)
• A cost-effectiveness analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk (Q35080762) (← links)
• Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study (Q35162642) (← links)
• Serum pepsinogen levels and their influencing factors: a population-based study in 6990 Chinese from North China (Q36178208) (← links)
• The clinical performance evaluation of novel protein chips for eleven biomarkers detection and the diagnostic model study (Q36492734) (← links)
• Helicobacter pylori gastritis, the unifying concept for gastric diseases (Q36996621) (← links)
• Ultrathin endoscope flexibility can predict discomfort associated with unsedated transnasal esophagogastroduodenoscopy (Q37011488) (← links)
• The adventures of sonic hedgehog in development and repair. IV. Sonic hedgehog processing, secretion, and function in the stomach (Q37097645) (← links)
• Asia-Pacific consensus guidelines on gastric cancer prevention (Q37101686) (← links)
• Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers (Q37537123) (← links)
• NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population (Q37702670) (← links)
• A magnetic nanoparticle-labeled immunoassay with europium and samarium for simultaneous quantification of serum pepsinogen I and II. (Q38776565) (← links)
• Atrophic gastritis and enlarged gastric folds diagnosed by double-contrast upper gastrointestinal barium X-ray radiography are useful to predict future gastric cancer development based on the 3-year prospective observation. (Q38951487) (← links)
• Evaluation of Pepsinogen I as a Biomarker of Drug-induced Gastric Mucosal Injury in Cynomolgus Monkeys (Q39071423) (← links)
• Novel risk markers for gastric cancer screening: Present status and future prospects (Q39800607) (← links)
• The serum pepsinogen levels for risk assessment of gastric neoplasms: New proposal from a case-control study in Korea (Q40116541) (← links)
• Serum pepsinogen reference intervals in apparently healthy Chinese population with latex enhanced turbidimetric immunoassay (Q43452551) (← links)
• The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea (Q45077882) (← links)
• Surveillance Strategy of Atrophic Gastritis and Intestinal Metaplasia in a Country with a High Prevalence of Gastric Cancer (Q45733753) (← links)
• Impact of pepsinogen C polymorphism on individual susceptibility to gastric cancer and its precancerous conditions in a Northeast Chinese population (Q45834551) (← links)
• Plasma expression of the intestinal metaplasia markers CDH17 and TFF3 in patients with gastric cancer (Q51029933) (← links)
• Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer (Q51303433) (← links)
• Reduced serum vascular endothelial growth factor receptor‐2 (sVEGFR‐2) and sVEGFR‐1 levels in gastric cancer patients (Q54621257) (← links)
• Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. (Q64900104) (← links)
• Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population (Q88034233) (← links)
• Pepsinogen Serology and Gastritis OLGA Staging in Mucosal Atrophy Assessment: A Cross-Sectional Study Involving East China Endoscopy Population (Q94464446) (← links)